An analysis released Friday by Democrats on the congressional Joint Economic Committee details how US President Donald Trump loaded up on shares of major pharmaceutical companies last year as his administration and Republican allies enacted policies that benefited the industry—at the expense seniors and other patients.The JEC analysis estimates that Trump increased his stock holdings in the pharmaceutical sector from $1.7 million in 2024 to...
Original Article: Raw Story
7 days ago
'Outrageous': Trump accused of making seniors 'pay more for cancer treatment' for profit
Boycott Vote
Should there be a boycott related to this issue?
Cast Your Boycott Vote
Yes — Support a boycott
0%
(0)
No — Do not boycott
0%
(0)
Community Vote
0 votes
No votes yet — be the first to vote
0 total votes